Inspired By Value, Driven By Vision

PATIENCE, PERSEVERANCE &
VISIONARY GROWTH STRATEGY

You are here:

Vision

To be USD 100 mn Speciality focussed organization by 2022.

Mission

Business: The founding pillars of our philosophy is to improve people’s lives by honoring our core value – Quality medicines at an affordable price.

Partners: To maximize the business potential of both domestic and international partners.

Ethics: To create value systems through dedicated & productivity driven team working in a symbiotic work culture achieving success for all.

milestones

A company’s journey is measured by the small steps it takes and success is measured by the milestones it has achieved.

2022

Unveiled New Office in Delhi
Launched Glutaup Nanoshots with Phytocell Technology and patented Bioperine extract
Launched patient education service on social media platform
Collaborated with e-pharmacies for better reach of our products

2021

Started Manufacturing Plant – Effikasia Lifesciences
Unveiled New Office in Mumbai
In- licensed Cerebroprotien (China)
Launched Cardio Diabetic Division
Launched Health Education Mobile app for patients – Alniche Health
Launched Health Info Portal – My Healthytude
Launched Training & Education portal for Alniche Sales Team – TED (TRAINING & EDUCATION DEPARTMENT)
Launching Onychomycosis treatment (Nailkalm) soon

2020

Launched Globally established Anti-dandruff Shampoo solution (Nizral)
Launched universally acclaimed Covid treatment portfolio (Remdesivir, Favipiravir, Imualfa)
Launched DRSC (Doctors’ Scientific Resource for Continuous Education) platform in collaboration with DPSRU (Delhi Pharmaceutical Science & Research University)
Launched Alniche Online Journal ( Healthcare e-Compendium)
Launched Topical Tissue Adhesive (Surgiseal and Surgiseal Stylus)

2019

Launched Neuropsychiatry division
Launched a novel product (Complipro & Ezepro) in collaboration with DPSRU, Govt. of N.C.T at Vigyan Bhavan under the graceful presence of Shri Anil Baijal (Honourable Lieutenant Governor, Govt. of N.C.T)
Launched Absorbable Adhesion Barrier Gel (Oxiplex /AP)

2018

In-Licensed-Topical Tissue Adhesive (USA).
Launced Woundcare Division (dermozone Range)
Launched TPN with Non-PVC 3 Chamber Bag (Combiklas)

2017

In-licensed Dermal Filler Range (Korea)
Launched Gastroenterology Division

2015

Launched Critical Care Division
Launched Skinceuticals Division

2010

Extended Nephrology Portfolio
With Renal Medicine Range
Launched Auxiliare Division With
Nutritional & Critical Care Range

2009

Moved to New Corporate Office

2008

Launched Nephrology Division With
Dialysis and Transplantation Portfolio

2007

Legal Inception of Alniche

OUR Achievement

A successful company is a result of collective actions of innovative leaders.